Posted On: 06/22/2016 8:13:59 AM
Post# of 23065

$MRNS: Marinus Pharmaceuticals Doses First Subject in Phase 1 Clinical Trial for Ganaxolone IV
http://www.nasdaq.com/press-release/marinus-p...0622-00169
http://www.nasdaq.com/press-release/marinus-p...0622-00169

